SITE011-0007

SITE011 (ITA) › SITE011-0007

SITE011-0007

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE011 (ITA) · Dr. Jansen
consented 2025-09-01

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-31 (study day 179); relationship: not assessed

moderate assessed

Grade 3 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-07-28 (study day 145); relationship: not assessed

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.